uploads///Part

What Analysts Are Recommending for Albemarle

By

Updated

Analyst recommendations for Albemarle

As of December 14, 2016, 16 brokerage firms are actively tracking Albemarle (ALB) stock. About 50.0% of these analysts have recommended a “buy” for the stock, while the remaining 50.0% have recommended a “hold.” None of the firms have recommended a “sell” for the stock.

The analyst consensus indicates a 12-month target price of $91.36 for Albemarle, which implies a return potential of 1.6% from its closing price of $89.94 on December 14, 2016.

Article continues below advertisement

Analysts have increased Albemarle’s target price from $91 in November to its current target price of $91.36. The higher recommendation could be due to better 3Q16 results and an upward earnings revision from 2016. Analysts may have also factored in price increases for some of the company’s products, which will be effective January 1, 2017.

Peer comparisons

  • As of December 2, 2016, ten brokerage firms are actively tracking W.R. Grace (GRA). About 50.0% of them have recommended a “buy” for the stock, while the remaining 50.0% have recommended a “hold.” None of the firms have recommended a “sell.”
  • FMC (FMC) is tracked actively by 19 brokerage firms. About 37.0% of them have recommended a “buy” for the stock, and 58.0% have recommended a “hold.” The remaining 5.0% have recommended a “sell.”

On December 13, 2016, UBS (UBS) revised Albemarle’s target price from $85 to $90, implying a marginal rise from the closing price of $89.94.

ETF investment

If you’re looking for exposure to Albemarle through ETFs, you can invest in the Guggenheim S&P 500 Equal Weight Materials ETF (RTM). RTM has invested 4.2% of its portfolio in Albemarle as of December 14, 2016.

Advertisement

More From Market Realist